跳至主要内容
临床试验/IRCT20201128049515N2
IRCT20201128049515N2招募中3 期

Evaluation the efficacy of hydroalcoholic extract of Melissa officinalis L. (Dracocephalum) in chemotherapy-induced peripheral neuropathy: A double-blinded randomized placebo-controlled clinical trial

Mazandaran University of Medical Sciences0 个研究点目标入组 74 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Patients with cancer between 18 to 75 years old
  • Patients who has received their first neurotoxic chemotherapy by using Vinca alkaloids, platinum and taxane derivatives.
  • Patients with neuropathy symptoms.

排除标准

  • Other possible reasons for neuropathy (diabetes, thyroid function disorder, B12 deficiency, alcohol abuse)
  • Taking other medications for neuropathy symptoms simultaneously
  • Taking any type of anti oxidant supplements in recent two months
  • Pregnant or nursing women

研究者

相似试验